168 related articles for article (PubMed ID: 22491505)
1. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis.
Mistro S; Maciel Ide M; de Menezes RG; Maia ZP; Schooley RT; Badaró R
Clin Infect Dis; 2012 Jun; 54(12):1774-7. PubMed ID: 22491505
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity of different formulations of amphotericin B: summarizing evidence by network meta-analysis.
Messori A; Fadda V; Maratea D; Trippoli S; Marinai C
Clin Infect Dis; 2013 Dec; 57(12):1783-4. PubMed ID: 24140972
[No Abstract] [Full Text] [Related]
3. Minimizing nephrotoxicity using continuous infusion of deoxycholate amphotericin B.
Gwee A; Cranswick N; Connell TG; Curtis N
Pediatr Infect Dis J; 2014 Oct; 33(10):1098. PubMed ID: 25361191
[No Abstract] [Full Text] [Related]
4. Lipid formulations of polyene antifungal drugs and attenuation of associated nephrotoxicity.
Razzaque MS; Hossain MA; Ahsan N; Taguchi T
Nephron; 2001 Nov; 89(3):251-4. PubMed ID: 11598385
[TBL] [Abstract][Full Text] [Related]
5. Persistent acute tubular toxicity after switch from conventional amphotericin B to liposomal amphotericin B (Ambisome).
Gerbaud E; Tamion F; Girault C; Clabault K; Lepretre S; Leroy J; Bonmarchand G
J Antimicrob Chemother; 2003 Feb; 51(2):473-5. PubMed ID: 12562731
[No Abstract] [Full Text] [Related]
6. Nephrotoxicity in the setting of invasive fungal diseases.
Ullmann AJ
Mycoses; 2008; 51 Suppl 1():25-30. PubMed ID: 18471158
[TBL] [Abstract][Full Text] [Related]
7. Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex.
Craddock C; Anson J; Chu P; Dodgson A; Duncan N; Gomez C; Mehta J; Sadullah S; Subudhi C; Yin JL
Expert Opin Drug Saf; 2010 Jan; 9(1):139-47. PubMed ID: 19947901
[TBL] [Abstract][Full Text] [Related]
8. Deoxycholate amphotericin B and nephrotoxicity in the pediatric setting.
Bes DF; Rosanova MT; Sberna N; Arrizurieta E
Pediatr Infect Dis J; 2014 Aug; 33(8):e198-206. PubMed ID: 24618932
[TBL] [Abstract][Full Text] [Related]
9. Reply to Messori et al.
Mistro S; Schooley RT; Badaro R
Clin Infect Dis; 2013 Dec; 57(12):1784-5. PubMed ID: 24140973
[No Abstract] [Full Text] [Related]
10. Liposomal amphotericin B for fever and neutropenia.
Patel MA; Curtis K; Maguire JH
N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515752
[No Abstract] [Full Text] [Related]
11. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
Maharom P; Thamlikitkul V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
[TBL] [Abstract][Full Text] [Related]
12. Lipid-based formulations of amphotericin B.
Plotnick AN
J Am Vet Med Assoc; 2000 Mar; 216(6):838-41. PubMed ID: 22570893
[No Abstract] [Full Text] [Related]
13. Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients.
Miller CB; Waller EK; Klingemann HG; Dignani MC; Anaissie EJ; Cagnoni PJ; McSweeney P; Fleck PR; Fruchtman SM; McGuirk J; Chao NJ
Bone Marrow Transplant; 2004 Mar; 33(5):543-8. PubMed ID: 14730342
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.
Steimbach LM; Tonin FS; Virtuoso S; Borba HH; Sanches AC; Wiens A; Fernandez-Llimós F; Pontarolo R
Mycoses; 2017 Mar; 60(3):146-154. PubMed ID: 27878878
[TBL] [Abstract][Full Text] [Related]
15. Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?
Karimzadeh I; Farsaei S; Khalili H; Dashti-Khavidaki S
Expert Opin Drug Saf; 2012 Nov; 11(6):969-83. PubMed ID: 22950480
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and management of amphotericin B-induced nephrotoxicity.
Miano-Mason TM
Cancer Pract; 1997; 5(3):176-81. PubMed ID: 9171554
[TBL] [Abstract][Full Text] [Related]
17. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.
Falci DR; da Rosa FB; Pasqualotto AC
Mycoses; 2015 Feb; 58(2):104-12. PubMed ID: 25590436
[TBL] [Abstract][Full Text] [Related]
18. Acute renal failure with amphotericin B in lipid emulsion.
Gales MA; Gales BJ; Alford KM
Ann Pharmacother; 1996 Sep; 30(9):1036. PubMed ID: 8876871
[No Abstract] [Full Text] [Related]
19. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of amphotericin B desoxycholate.
Girmenia C; Gentile G; Micozzi A; Martino P
Clin Infect Dis; 2001 Sep; 33(6):915-6. PubMed ID: 11512101
[No Abstract] [Full Text] [Related]
[Next] [New Search]